{"id":"https://openalex.org/W2145357583","doi":null,"title":"Preliminary studies on phenothiazine-mediated reversal of multidrug resistance in mouse lymphoma and COLO 320 cells.","display_name":"Preliminary studies on phenothiazine-mediated reversal of multidrug resistance in mouse lymphoma and COLO 320 cells.","publication_year":2005,"publication_date":"2005-11-01","ids":{"openalex":"https://openalex.org/W2145357583","mag":"2145357583","pmid":"https://pubmed.ncbi.nlm.nih.gov/16277030"},"language":"en","primary_location":{"id":"pmid:16277030","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16277030","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"In vivo (Athens, Greece)","raw_type":"Comparative Study"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017817748","display_name":"Beata Paj\u0105k","orcid":"https://orcid.org/0000-0002-3565-8860","observed_orcids":["https://orcid.org/0000-0002-3565-8860"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Beata Pajak","raw_affiliation_strings":["Department of Physiological Sciences, Faculty of Veterinary Medicine, Warsaw Agricultural University, ul. Nowoursynowska 159, 02-776 Warsaw, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Physiological Sciences, Faculty of Veterinary Medicine, Warsaw Agricultural University, ul. Nowoursynowska 159, 02-776 Warsaw, Poland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058006275","display_name":"Joseph Andrew Molnar","orcid":"https://orcid.org/0000-0003-2254-6269","observed_orcids":["https://orcid.org/0000-0003-2254-6269"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joseph Molnar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053834551","display_name":"Helga Engi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Helga Engi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"Arkadiusz Orzechowski","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Arkadiusz Orzechowski","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.2061,"has_fulltext":false,"cited_by_count":21,"citation_normalized_percentile":{"value":0.79943259,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"19","issue":"6","first_page":"1101","last_page":"4"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/phenothiazines","display_name":"phenothiazines","score":0.8460000157356262},{"id":"https://openalex.org/keywords/multidrug-resistance-reversal","display_name":"multidrug resistance reversal","score":0.9890000224113464},{"id":"https://openalex.org/keywords/p-glycoprotein","display_name":"P-glycoprotein","score":0.8949999809265137},{"id":"https://openalex.org/keywords/drug-efflux-inhibition","display_name":"drug efflux inhibition","score":0.7630000114440918},{"id":"https://openalex.org/keywords/rhodamine-123-efflux","display_name":"rhodamine 123 efflux","score":0.9539999961853027},{"id":"https://openalex.org/keywords/perphenazine","display_name":"perphenazine","score":0.859000027179718},{"id":"https://openalex.org/keywords/prochlorperazine","display_name":"prochlorperazine","score":0.8980000019073486},{"id":"https://openalex.org/keywords/intracellular-drug-accumulation","display_name":"intracellular drug accumulation","score":0.7950000166893005},{"id":"https://openalex.org/keywords/cytotoxicity","display_name":"cytotoxicity","score":0.7990000247955322},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.7549999952316284},{"id":"https://openalex.org/keywords/mouse-lymphoma-cells","display_name":"mouse lymphoma cells","score":0.7419999837875366},{"id":"https://openalex.org/keywords/cancer-cells","display_name":"cancer cells","score":0.42899999022483826}],"concepts":[{"id":"https://openalex.org/C2778716775","wikidata":"https://www.wikidata.org/wiki/Q410846","display_name":"Phenothiazine","level":2,"score":0.8865073919296265},{"id":"https://openalex.org/C2778589691","wikidata":"https://www.wikidata.org/wiki/Q3429577","display_name":"Rhodamine 123","level":4,"score":0.861970067024231},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.7171120643615723},{"id":"https://openalex.org/C133936738","wikidata":"https://www.wikidata.org/wiki/Q643839","display_name":"Multiple drug resistance","level":3,"score":0.6578722596168518},{"id":"https://openalex.org/C200082930","wikidata":"https://www.wikidata.org/wiki/Q22327148","display_name":"Efflux","level":2,"score":0.6260011792182922},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6196522116661072},{"id":"https://openalex.org/C2776743534","wikidata":"https://www.wikidata.org/wiki/Q423520","display_name":"Perphenazine","level":2,"score":0.5448323488235474},{"id":"https://openalex.org/C2778775820","wikidata":"https://www.wikidata.org/wiki/Q407972","display_name":"Chlorpromazine","level":2,"score":0.5331702828407288},{"id":"https://openalex.org/C2778707650","wikidata":"https://www.wikidata.org/wiki/Q412902","display_name":"P-glycoprotein","level":4,"score":0.525609016418457},{"id":"https://openalex.org/C2778794651","wikidata":"https://www.wikidata.org/wiki/Q422970","display_name":"Promethazine","level":2,"score":0.5129013061523438},{"id":"https://openalex.org/C79879829","wikidata":"https://www.wikidata.org/wiki/Q5571762","display_name":"Intracellular","level":2,"score":0.504050612449646},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.46096181869506836},{"id":"https://openalex.org/C2781324269","wikidata":"https://www.wikidata.org/wiki/Q2359690","display_name":"Prochlorperazine","level":3,"score":0.4573066532611847},{"id":"https://openalex.org/C553184892","wikidata":"https://www.wikidata.org/wiki/Q1141429","display_name":"Flow cytometry","level":2,"score":0.42646223306655884},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.24751892685890198},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.21127918362617493},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.10400444269180298},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.08605965971946716},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.0820782482624054},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.0532817542552948}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001692","descriptor_name":"Biological Transport","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003110","descriptor_name":"Colonic Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003110","descriptor_name":"Colonic Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D003110","descriptor_name":"Colonic Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D005434","descriptor_name":"Flow Cytometry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005456","descriptor_name":"Fluorescent Dyes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010546","descriptor_name":"Perphenazine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010546","descriptor_name":"Perphenazine","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D010640","descriptor_name":"Phenothiazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D010640","descriptor_name":"Phenothiazines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D011346","descriptor_name":"Prochlorperazine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011346","descriptor_name":"Prochlorperazine","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D012235","descriptor_name":"Rhodamines","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016399","descriptor_name":"Lymphoma, T-Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016399","descriptor_name":"Lymphoma, T-Cell","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D016399","descriptor_name":"Lymphoma, T-Cell","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D018432","descriptor_name":"Drug Resistance, Multiple","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D018432","descriptor_name":"Drug Resistance, Multiple","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D019450","descriptor_name":"Genes, MDR","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D020168","descriptor_name":"ATP Binding Cassette Transporter, Subfamily B, Member 1","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:16277030","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16277030","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"In vivo (Athens, Greece)","raw_type":"Comparative Study"},{"id":"mag:2145357583","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16277030","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":14,"referenced_works":["https://openalex.org/W38240870","https://openalex.org/W78133828","https://openalex.org/W1499694712","https://openalex.org/W2003464317","https://openalex.org/W2006434892","https://openalex.org/W2021759214","https://openalex.org/W2066968597","https://openalex.org/W2104832934","https://openalex.org/W2415640694","https://openalex.org/W2415644560","https://openalex.org/W2418704381","https://openalex.org/W2419195729","https://openalex.org/W2419654650","https://openalex.org/W2468777618"],"related_works":["https://openalex.org/W7058422884","https://openalex.org/W2418704381","https://openalex.org/W1762773183","https://openalex.org/W2415644560","https://openalex.org/W2076999630","https://openalex.org/W2061177237","https://openalex.org/W78133828","https://openalex.org/W2023184445","https://openalex.org/W2160966068","https://openalex.org/W2751161242"],"abstract_inverted_index":{"The":[0,90,121],"ability":[1],"of":[2,10,34,43,57,96,108,123,132],"phenothiazine":[3,45,63],"derivatives":[4,64],"to":[5,53],"inhibit":[6],"the":[7,27,32,44,58,75,94,97,106],"transport":[8],"activity":[9],"P-glycoprotein":[11],"in":[12,31,79,110,137,141],"resistant":[13,81],"mouse":[14],"lymphoma":[15],"and":[16,49],"MDR/COLO":[17],"320":[18],"cells":[19,30],"was":[20,37],"studied.":[21],"A":[22],"rhodamine":[23,59],"123":[24],"efflux":[25],"from":[26],"above-mentioned":[28],"neoplastic":[29],"presence":[33],"tested":[35,62],"compounds":[36,99,133],"examined":[38],"by":[39],"flow":[40],"cytometry.":[41],"Two":[42],"derivatives,":[46],"namely":[47],"perphenazine":[48],"prochlorperazine":[50],"dimaleate,":[51],"proved":[52],"be":[54,105],"effective":[55],"inhibitors":[56],"efflux.":[60],"Other":[61],"(promethazine":[65],"hydrochloride,":[66,71],"oxomemazine,":[67],"methotrimeprazine":[68],"maleate,":[69],"trifluoropromazine":[70],"trimeprazine)":[72],"also":[73],"modulated":[74],"intracellular":[76,101],"drug":[77,102],"accumulation":[78,103],"both":[80],"cell":[82],"lines,":[83],"however,":[84],"they":[85],"exerted":[86],"additional":[87],"cytotoxic":[88],"effects.":[89],"differences":[91,109],"observed":[92],"between":[93],"effects":[95],"test":[98],"on":[100],"could":[104],"outcome":[107],"phenothiazine's":[111],"chemical":[112],"structure,":[113],"which":[114],"is":[115],"crucial":[116],"for":[117],"drug-cell":[118],"membrane":[119],"interactions.":[120],"results":[122],"this":[124],"study":[125],"provide":[126],"information":[127],"about":[128],"a":[129],"new":[130],"group":[131],"that":[134],"offer":[135],"promise":[136],"multidrug":[138],"resistance":[139],"reversal":[140],"tumor":[142],"cells.":[143]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}